Kirkeby Cell Therapy APS — Credit Rating and Financial Key Figures

Kirkeby Cell Therapy APS (CVR number: 38650165) is a company from GENTOFTE. The company recorded a gross profit of 59.5 kDKK in 2024. The operating profit was 59.5 kDKK, while net earnings were 111.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 8.2 %, which can be considered good but Return on Equity (ROE) was 6.5 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 98.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Kirkeby Cell Therapy APS's liquidity measured by quick ratio was 73.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.